Renaissance Technologies’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-96,042
Closed -$22.1K 3951
2024
Q4
$22.1K Sell
96,042
-393
-0.4% -$90 ﹤0.01% 3478
2024
Q3
$207K Sell
96,435
-21,000
-18% -$45.2K ﹤0.01% 3116
2024
Q2
$606K Sell
117,435
-2,400
-2% -$12.4K ﹤0.01% 2607
2024
Q1
$641K Buy
119,835
+61,200
+104% +$327K ﹤0.01% 2765
2023
Q4
$457K Buy
58,635
+9,400
+19% +$73.3K ﹤0.01% 2821
2023
Q3
$194K Buy
49,235
+3,100
+7% +$12.2K ﹤0.01% 3102
2023
Q2
$145K Buy
46,135
+300
+0.7% +$943 ﹤0.01% 3377
2023
Q1
$122K Sell
45,835
-1,400
-3% -$3.73K ﹤0.01% 3426
2022
Q4
$170K Buy
47,235
+3,500
+8% +$12.6K ﹤0.01% 3474
2022
Q3
$282K Buy
43,735
+834
+2% +$5.38K ﹤0.01% 3239
2022
Q2
$413K Sell
42,901
-38,995
-48% -$375K ﹤0.01% 3267
2022
Q1
$975K Buy
+81,896
New +$975K ﹤0.01% 2739
2021
Q1
Sell
-8,670
Closed -$941K 3792
2020
Q4
$941K Buy
+8,670
New +$941K ﹤0.01% 2527
2020
Q3
Sell
-5,830
Closed -$621K 3763
2020
Q2
$621K Buy
+5,830
New +$621K ﹤0.01% 2788
2020
Q1
Sell
-12,909
Closed -$892K 3884
2019
Q4
$892K Sell
12,909
-15,751
-55% -$1.09M ﹤0.01% 2685
2019
Q3
$2.98M Sell
28,660
-1,080
-4% -$112K ﹤0.01% 2065
2019
Q2
$2.75M Buy
29,740
+7,690
+35% +$712K ﹤0.01% 2164
2019
Q1
$2.02M Buy
22,050
+9,580
+77% +$875K ﹤0.01% 2303
2018
Q4
$695K Buy
12,470
+9,640
+341% +$537K ﹤0.01% 2734
2018
Q3
$337K Sell
2,830
-13,660
-83% -$1.63M ﹤0.01% 2979
2018
Q2
$1.68M Buy
+16,490
New +$1.68M ﹤0.01% 2357
2017
Q4
Sell
-7,220
Closed -$1.06M 3529
2017
Q3
$1.06M Buy
7,220
+4,520
+167% +$665K ﹤0.01% 2551
2017
Q2
$434K Buy
+2,700
New +$434K ﹤0.01% 2801